Lisa Dobbyn

7.7k total citations
7 papers, 234 citations indexed

About

Lisa Dobbyn is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Lisa Dobbyn has authored 7 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Lisa Dobbyn's work include Cancer Genomics and Diagnostics (7 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Genetic factors in colorectal cancer (3 papers). Lisa Dobbyn is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Genetic factors in colorectal cancer (3 papers). Lisa Dobbyn collaborates with scholars based in United States, Australia and Sweden. Lisa Dobbyn's co-authors include Maria Popoli, Nickolas Papadopoulos, Jeanne Tie, Kenneth W. Kinzler, Natalie Silliman, Joshua D. Cohen, Bert Vogelstein, Peter Gibbs, Janine Ptak and Joy Schaefer and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and Cancer Discovery.

In The Last Decade

Lisa Dobbyn

7 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Dobbyn United States 4 185 140 110 67 56 7 234
Eisaku Furukawa Japan 5 184 1.0× 173 1.2× 80 0.7× 78 1.2× 99 1.8× 7 274
Amanda Frydendahl Denmark 7 190 1.0× 139 1.0× 95 0.9× 65 1.0× 44 0.8× 15 228
Wenzhuan Xie China 8 98 0.5× 114 0.8× 54 0.5× 109 1.6× 97 1.7× 18 238
M. Milder France 4 154 0.8× 182 1.3× 38 0.3× 121 1.8× 64 1.1× 8 283
Mayra Orrillo Spain 3 229 1.2× 186 1.3× 151 1.4× 98 1.5× 42 0.8× 7 269
Santosh Gupta United States 6 106 0.6× 122 0.9× 30 0.3× 163 2.4× 73 1.3× 15 246
Carmela Rodríguez Spain 3 239 1.3× 191 1.4× 151 1.4× 98 1.5× 54 1.0× 5 285
Luca Paglialunga Italy 7 135 0.7× 119 0.8× 32 0.3× 129 1.9× 167 3.0× 12 320
Audelaure Junca France 6 74 0.4× 140 1.0× 110 1.0× 30 0.4× 57 1.0× 8 212
Rachel Galot Belgium 7 130 0.7× 92 0.7× 24 0.2× 86 1.3× 90 1.6× 26 221

Countries citing papers authored by Lisa Dobbyn

Since Specialization
Citations

This map shows the geographic impact of Lisa Dobbyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Dobbyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Dobbyn more than expected).

Fields of papers citing papers by Lisa Dobbyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Dobbyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Dobbyn. The network helps show where Lisa Dobbyn may publish in the future.

Co-authorship network of co-authors of Lisa Dobbyn

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Dobbyn. A scholar is included among the top collaborators of Lisa Dobbyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Dobbyn. Lisa Dobbyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wang, Yuxuan, Corinne E. Joshu, Christopher Douville, et al.. (2025). Data from Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA. 1 indexed citations
2.
Wang, Yuxuan, Corinne E. Joshu, Christopher Douville, et al.. (2025). Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA. Cancer Discovery. 15(9). 1794–1802. 3 indexed citations
3.
Lee, Belinda, Jeanne Tie, Yuxuan Wang, et al.. (2024). The potential role of serial circulating tumor DNA (ctDNA) testing after upfront surgery to guide adjuvant chemotherapy for early stage pancreatic cancer: The AGITG DYNAMIC-Pancreas trial.. Journal of Clinical Oncology. 42(16_suppl). 107–107. 11 indexed citations
4.
Tie, Jeanne, Joshua D. Cohen, Yuxuan Wang, et al.. (2024). Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study.. Journal of Clinical Oncology. 42(3_suppl). 12–12. 24 indexed citations
5.
Ananda, Sumitra, Yuxuan Wang, Wei Hong, et al.. (2023). Circulating tumor DNA (ctDNA) as a marker of residual disease and recurrence in resected stage I-IV epithelial ovarian cancer (EOC).. Journal of Clinical Oncology. 41(16_suppl). 5553–5553. 2 indexed citations
6.
Cohen, Joshua D., Christopher Douville, Jonathan C. Dudley, et al.. (2021). Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands. Nature Biotechnology. 39(10). 1220–1227. 44 indexed citations
7.
Wang, Yuxuan, Lu Li, Joshua D. Cohen, et al.. (2019). Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer. JAMA Oncology. 5(8). 1118–1118. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026